Medical Properties Trust, Inc. (MPT)
Official siteREAL ESTATE • REIT - HEALTHCARE FACILITIES • NYSE
Market Cap: $983.46M
Last updated: Nov 17, 2026 at 11:06 AM ET
Medical Properties Trust, Inc. (MPT) Earnings: Report Dates and Results
FFO per share for Medical Properties Trust (MPT) was $0.52 for 2025. In the quarter ended Sep 30, 2026, Medical Properties Trust reported EPS of $0.11, below the $0.13 estimate. It beat the EPS estimate in 2 of the 8 most recent quarters that had an estimate. Medical Properties Trust is expected to report earnings on Feb 17, 2027.
Earnings
Performance (10Y)
Upcoming Estimates
Next Report
MPT has an expected report date of Feb 17, 2027.
MPT Earnings Call
The latest MPT earnings call transcript on file is labeled 2026Q3.
Read the 2026Q3 transcriptEarnings History
Of the 37 quarters below that had an estimate, MPT beat 6, missed 25 and matched 6. Revenue for the quarter ended Sep 30, 2026 was $250.14M, up 5.3% from $237.52M a year earlier.
| Quarter ended | EPS | Estimate | Range | Surprise | Result | YoY | Analysts | Revisions | Reported | Revenue |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2026 | $0.11 | $0.13 | N/A | -15.38% | Miss | N/A | 1 | 0 up, 0 down | Oct 29, 2026 | $250.14M |
| Jun 30, 2026 | $0.15 | $0.16 | N/A | -6.25% | Miss | N/A | 1 | 0 up, 1 down | Aug 10, 2026 | $259.28M |
| Mar 31, 2026 | $0.09 | $0.01 | $0.00 - $0.01 | +800.00% | Beat | N/A | 2 | 0 up, 1 down | Apr 30, 2026 | $252.06M |
| Dec 31, 2025 | $0.03 | $0.02 | N/A | +50.00% | Beat | N/A | N/A | N/A | Feb 19, 2026 | $270.34M |
| Sep 30, 2025 | -$0.13 | $0.02 | N/A | -750.00% | Miss | N/A | N/A | N/A | Oct 30, 2025 | $237.52M |
| Jun 30, 2025 | -$0.16 | $0.02 | N/A | -900.00% | Miss | -500.0% | N/A | N/A | Jul 31, 2025 | $240.36M |
| Mar 31, 2025 | -$0.20 | -$0.01 | N/A | N/A | N/A | N/A | N/A | N/A | May 1, 2025 | $223.80M |
| Dec 31, 2024 | -$0.69 | -$0.06 | N/A | N/A | N/A | N/A | N/A | N/A | Feb 27, 2025 | $235.27M |
| Sep 30, 2024 | -$0.09 | $0.10 | N/A | -190.00% | Miss | -145.0% | N/A | N/A | Nov 7, 2024 | $225.83M |
| Jun 30, 2024 | $0.04 | $0.10 | N/A | -60.00% | Miss | N/A | N/A | N/A | Aug 8, 2024 | $266.56M |
| Mar 31, 2024 | -$0.07 | $0.11 | N/A | -163.64% | Miss | -135.0% | N/A | N/A | May 9, 2024 | $271.32M |
| Dec 31, 2023 | -$0.63 | $0.16 | N/A | -493.75% | Miss | N/A | N/A | N/A | Feb 21, 2024 | N/A |
| Sep 30, 2023 | $0.20 | $0.19 | N/A | +5.26% | Beat | -23.1% | N/A | N/A | Oct 26, 2023 | $306.58M |
| Jun 30, 2023 | -$0.07 | $0.20 | N/A | -135.00% | Miss | -124.1% | N/A | N/A | Aug 8, 2023 | $349.62M |
| Mar 31, 2023 | $0.20 | $0.22 | N/A | -9.09% | Miss | -33.3% | N/A | N/A | Apr 27, 2023 | $361.56M |
| Dec 31, 2022 | -$0.24 | N/A | N/A | N/A | N/A | -187.3% | N/A | N/A | Feb 23, 2023 | $387.68M |
| Sep 30, 2022 | $0.26 | $0.30 | N/A | -13.33% | Miss | -3.7% | N/A | N/A | Oct 27, 2022 | $363.82M |
| Jun 30, 2022 | $0.29 | $0.31 | N/A | -6.45% | Miss | +45.0% | N/A | N/A | Aug 3, 2022 | $415.01M |
| Mar 31, 2022 | $0.30 | $0.32 | N/A | -6.25% | Miss | +7.1% | N/A | N/A | Apr 28, 2022 | $417.14M |
| Dec 31, 2021 | $0.27 | $0.32 | N/A | -15.63% | Miss | +35.0% | N/A | N/A | Feb 3, 2022 | $416.19M |
| Sep 30, 2021 | $0.27 | $0.29 | N/A | -6.90% | Miss | +8.0% | N/A | N/A | Oct 28, 2021 | $397.97M |
| Jun 30, 2021 | $0.20 | $0.30 | N/A | -33.33% | Miss | -4.8% | N/A | N/A | Jul 29, 2021 | $389.13M |
| Mar 31, 2021 | $0.28 | $0.25 | N/A | +12.00% | Beat | +47.4% | N/A | N/A | Apr 29, 2021 | $369.87M |
| Dec 31, 2020 | $0.20 | $0.28 | N/A | -28.57% | Miss | -9.1% | N/A | N/A | Feb 4, 2021 | $338.96M |
| Sep 30, 2020 | $0.25 | $0.26 | N/A | -3.85% | Miss | +25.0% | N/A | N/A | Oct 29, 2020 | $335.35M |
| Jun 30, 2020 | $0.21 | $0.25 | N/A | -16.00% | Miss | +5.0% | N/A | N/A | Jul 30, 2020 | $297.13M |
| Mar 31, 2020 | $0.19 | $0.30 | N/A | -36.67% | Miss | -5.0% | N/A | N/A | Apr 29, 2020 | $298.21M |
| Dec 31, 2019 | $0.22 | $0.22 | N/A | 0.00% | In line | 0.0% | N/A | N/A | Feb 6, 2020 | $260.85M |
| Sep 30, 2019 | $0.20 | $0.20 | N/A | 0.00% | In line | -20.0% | N/A | N/A | Oct 31, 2019 | $224.76M |
| Jun 30, 2019 | $0.20 | $0.19 | N/A | +5.26% | Beat | -16.7% | N/A | N/A | Aug 1, 2019 | $192.55M |
| Mar 31, 2019 | $0.20 | $0.22 | N/A | -9.09% | Miss | -20.0% | N/A | N/A | May 2, 2019 | $180.45M |
| Dec 31, 2018 | $0.22 | $0.22 | N/A | 0.00% | In line | -4.3% | N/A | N/A | Feb 7, 2019 | $180.58M |
| Sep 30, 2018 | $0.25 | $0.25 | N/A | 0.00% | In line | +19.0% | N/A | N/A | Nov 1, 2018 | $197.00M |
| Jun 30, 2018 | $0.24 | $0.26 | N/A | -7.69% | Miss | +14.3% | N/A | N/A | Aug 2, 2018 | $201.90M |
| Mar 31, 2018 | $0.25 | $0.27 | N/A | -7.41% | Miss | +4.2% | N/A | N/A | May 3, 2018 | $205.05M |
| Dec 31, 2017 | $0.23 | $0.23 | N/A | 0.00% | In line | +76.9% | N/A | N/A | Feb 8, 2018 | $204.96M |
| Sep 30, 2017 | $0.21 | $0.22 | N/A | -4.55% | Miss | +5.0% | N/A | N/A | Nov 2, 2017 | $176.58M |
| Jun 30, 2017 | $0.21 | $0.21 | N/A | 0.00% | In line | -19.2% | N/A | N/A | Aug 9, 2017 | $166.81M |
| Mar 31, 2017 | $0.24 | $0.21 | N/A | +14.29% | Beat | 0.0% | N/A | N/A | May 4, 2017 | $156.40M |
| Dec 31, 2016 | $0.13 | $0.20 | N/A | -35.00% | Miss | -50.0% | N/A | N/A | Feb 9, 2017 | $153.28M |
Annual FFO
FFO per share was $0.52 for 2025, down 10.3% from $0.58 in 2024. It was $1.26 for 2016, the oldest of the 10 years shown.
| Fiscal year | FFO per share | Change |
|---|---|---|
| 2025 | $0.52 | -10.3% |
| 2024 | $0.58 | -68.1% |
| 2023 | $1.82 | +4.0% |
| 2022 | $1.75 | +11.5% |
| 2021 | $1.57 | +20.8% |
| 2020 | $1.30 | -5.1% |
| 2019 | $1.37 | +1.5% |
| 2018 | $1.35 | +5.5% |
| 2017 | $1.28 | +1.6% |
| 2016 | $1.26 | N/A |
Annual EPS
EPS for the fiscal year ended Dec 31, 2025 was -$0.46, after -$0.81 the year before. It was $0.83 for the year ended Dec 31, 2016, the oldest of the 10 fiscal years shown.
| Fiscal year ended | EPS | Change |
|---|---|---|
| Dec 31, 2025 | -$0.46 | N/A |
| Dec 31, 2024 | -$0.81 | N/A |
| Dec 31, 2023 | -$0.30 | -148.8% |
| Dec 31, 2022 | $0.61 | -39.8% |
| Dec 31, 2021 | $1.02 | +20.0% |
| Dec 31, 2020 | $0.85 | N/A |
| Dec 31, 2019 | $0.82 | -14.6% |
| Dec 31, 2018 | $0.96 | +7.9% |
| Dec 31, 2017 | $0.89 | +7.2% |
| Dec 31, 2016 | $0.83 | N/A |
Earnings Calls
The 8 most recent earnings calls are listed below; the latest, 2026Q3 for the period ended Sep 30, 2026, runs about 3,400 words across 9 speakers.
| Call | Period ending | Words | Speakers | Transcript |
|---|---|---|---|---|
| 2026Q3 | Sep 30, 2026 | 3,433 | 9 | |
| 2026Q2 | Jun 30, 2026 | 4,549 | 12 | |
| 2025Q4 | Dec 31, 2025 | 4,534 | 13 | |
| 2025Q3 | Sep 30, 2025 | 4,017 | 10 | |
| 2025Q2 | Jun 30, 2025 | 4,602 | 11 | |
| 2025Q1 | Mar 31, 2025 | 4,944 | 10 | |
| 2024Q4 | Dec 31, 2024 | 5,908 | 13 | |
| 2024Q3 | Sep 30, 2024 | 3,898 | 9 |
2026Q3 Earnings Call
Opening remarks
Charles Lambert Senior Vice President Good morning. Welcome to the MPT conference call to discuss our third quarter 2026 financial results. With me today are Edward K. Aldag, Jr., Chairman, President and Chief Executive Officer of the company; Steven Hamner, Executive Vice President and Chief Financial Officer; Kevin Hanna, Senior Vice President, Controller and Chief Accounting Officer; Rosa Williams, Senior Vice President of Operations and Secretary; and Jason Frey, Managing Director, Asset Management and Underwriting. Our press release was distributed this morning and furnished on Form 8-K with the Securities and Exchange Commission. If you did not receive a copy, it is available on our website at mpt.com in the Investor Relations section. Additionally, we're hosting a live webcast of today's call, which you can access in that same section. During the course of this call, we will make projections and certain other statements that may be considered forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are subject to known and unknown risks, uncertainties and other factors that may cause our financial results and future events to differ materially from those expressed in or underlying such forward-looking statements. We refer you to the company's reports filed with the Securities and Exchange Commission for a discussion of the factors that could cause the company's actual results or future events to differ materially from those expressed in this call. The information being provided today is as of this date only, and except as required by the federal securities laws, the company does not undertake a duty to update any such information. In addition, during the course of the conference call, we will describe certain non-GAAP financial measures, which should be considered in addition to and not in lieu of comparable GAAP financial measures. Please note that in our press release, MPT has reconciled all non-GAAP financial measures to the most directly comparable GAAP measures in accordance with Regulation G requirements. You can also refer to our website at mpt.com for the most directly comparable financial measures and related reconciliations. I will now turn the call over to our Chief Executive Officer, Ed Aldag.
Edward Aldag Chairman, President and Chief Executive Officer Thank you, Charles, and thank all of you for joining us this morning. Earlier this year, we projected MPT would reach annualized cash rental revenue of at least $1 billion by the end of this year. Year-to-date, we have already collected more than $750 million of cash revenue, which annualizes to more than the $1 billion we projected earlier. This reflects the strength of our diverse portfolio of operators around the world. During the year, we've sold 9 properties for cash proceeds of approximately $600 million, and we still hit our target.
Frequently Asked Questions About MPT
When is Medical Properties Trust's next earnings date?
Medical Properties Trust's next earnings report is expected for Feb 17, 2027.
Did MPT beat earnings estimates last quarter?
No. Medical Properties Trust reported EPS of $0.11 for the quarter ended Sep 30, 2026, below the $0.13 estimate by 15.38%.
What EPS do analysts expect from MPT next quarter?
The consensus EPS estimate for Medical Properties Trust for the quarter ending Dec 31, 2026 is -$0.02 from 6 analysts, with estimates from -$0.05 to $0.07.
How often does MPT beat earnings estimates?
Medical Properties Trust beat the EPS estimate in 2 of the 8 most recent quarters that had an estimate, with an average surprise of -133.95%.
MPT pages: Overview, Dividends, Earnings, Forecast, Financials, Valuation, Competitors